Consolidated Statements of Cash Flows
(Millions of yen)
| Year ended March 31, 2021 |
Year ended March 31, 2022 |
Year ended March 31, 2023 |
Year ended March 31, 2024 |
Year ended March 31, 2025 |
Year ended March 31, 2026 |
|
|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||
| Profit for the period | 30,995 | 92,302 | 75,051 | 52,620 | 55,181 | 18,206 |
| Depreciation and amortization | 69,852 | 64,595 | 68,696 | 68,682 | 72,142 | 77,417 |
| Impairment loss and reversal of impairment loss | 7,823 | 1,460 | 1,966 | 1,339 | 1,256 | 29,238 |
| Finace (income) costs | 2,820 | (2,569) | (6,604) | (12,537) | (3,280) | (479) |
| Share of (profit) loss of investments accounted for using the equity method | (99) | (113) | (105) | (23) | (7) | 14 |
| Loss (gain) on sales and disposal of property, plant and equipment, intangible assets and investment property | 316 | 232 | (716) | 532 | 92 | 681 |
| Income taxes | 13,937 | 4,859 | 28,703 | 17,473 | 23,214 | 31,817 |
| Decrease (increase) in trade receivables | (1,004) | 3,006 | (22,131) | 4,370 | 3,500 | (13,737) |
| Decrease (increase) in inventories | (12,865) | (28,230) | (60,253) | 71,097 | (15,780) | 2,546 |
| Increase (decrease) in trade payables | 13,151 | 2,175 | (1,645) | (7,921) | 2,562 | (967) |
| Increase (decrease) in net defined benefit liabilities | 2,888 | 1,532 | (799) | 663 | 1,648 | 60 |
| Other | 14,779 | (6,428) | 11,100 | (10,957) | 16,985 | 165 |
| Subtotal | 142,595 | 132,823 | 93,260 | 185,340 | 157,517 | 144,962 |
| Interest and dividend income received | 1,365 | 1,470 | 3,339 | 4,931 | 6,187 | 4,611 |
| Interest expenses paid | (1,111) | (1,071) | (1,208) | (1,821) | (1,543) | (2,389) |
| Proceeds from insurance income | 339 | - | - | - | 255 | 2,023 |
| Income taxes paid | (9,966) | (22,420) | (34,080) | (22,879) | (24,341) | (36,836) |
| Net cash provided by (used in) operating activities | 133,222 | 110,801 | 61,311 | 165,570 | 138,075 | 112,372 |
| Cash flows from investing activities | ||||||
| Purchase of investment securities | (297) | (747) | (827) | (1,371) | (1,092) | (1,916) |
| Proceeds from sales of investment securities | 26 | 622 | 154 | 1,004 | 5,708 | 2,615 |
| Purchase of property, plant and equipment | (47,504) | (38,602) | (50,551) | (49,570) | (59,369) | (54,615) |
| Proceeds from sales of property, plant and equipment | 467 | 245 | 1,058 | 404 | 621 | 727 |
| Purchase of intangible assets | (8,371) | (5,242) | (8,545) | (7,023) | (10,897) | (6,234) |
| Proceeds from sales of intangible assets | 21 | 33 | 21 | 15 | 13 | - |
| Proceeds from sales of investment property | - | 352 | 1,985 | - | 88 | 131 |
| Purchase of investments in subsidiaries | - | - | - | - | (85,483) | (2,053) |
| Other | (1,790) | (746) | (4,897) | (2,440) | (375) | (4,215) |
| Net cash provided by (used in) investing activities | (57,448) | (44,083) | (61,602) | (58,981) | (150,787) | (65,561) |
| Cash flows from financing activities | ||||||
| Net increase (decrease) in current borrowings | (889) | - | 9 | 502 | (567) | 36,096 |
| Proceeds from non-current borrowings | - | 500 | - | - | - | 30,000 |
| Repayments of non-current borrowings | (14,000) | (500) | (18,000) | - | (9,000) | (30,000) |
| Proceeds from issuance of bonds issued | 69,676 | - | - | - | 39,823 | - |
| Redemption of bonds issued | - | (20,000) | - | (30,000) | (10,000) | (40,000) |
| Payments of lease obligations | (9,667) | (8,275) | (10,003) | (10,033) | (10,989) | (11,990) |
| Dividends paid | (21,449) | (21,451) | (21,313) | (25,862) | (24,372) | (23,708) |
| Dividends paid to non-controlling interests | (519) | (394) | (0) | (0) | (0) | 0 |
| Payments for purchase of subsidiaries' equity from non-controlling interests | - | (1,648) | - | - | - | - |
| Purchase of treasury shares | (1) | (1) | (30,042) | (1) | (30,022) | (1) |
| Net cash provided by (used in) financing activities | 23,150 | (51,771) | (79,349) | (65,395) | (45,129) | (39,604) |
| Effect of exchange rate changes on cash and cash equivalents | 8,837 | 16,285 | 11,781 | 19,907 | (3,640) | 14,376 |
| Net increase (decrease) in cash and cash equivalents | 107,761 | 31,232 | (67,859) | 61,100 | (61,481) | 21,581 |
| Cash and cash equivalents at beginning of period | 196,245 | 304,007 | 335,239 | 267,380 | 328,481 | 267,000 |
| Cash and cash equivalents at end of period | 304,007 | 335,239 | 267,380 | 328,481 | 267,000 | 288,582 |
Official Account
